Tag: SARS-CoV-2

Coronavirus infection increases risk of developing insulin resistance

March 24, 2022

Infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2 virus) leads to activation of the immune system and subsequent release of pro-inflammatory signaling substances (cytokines). Studies show that this immune system activity persists for months after a coronavirus infection and even affects the human pancreas thus impairing insulin secretion and effectiveness – a hallmark […]

Continue Reading

Singapore succeeds in detection of Covid-19 variant in wastewater

July 21, 2021

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, alongside collaborators from Biobot Analytics, Nanyang Technological University (NTU) and Massachusetts Institute of Technology (MIT), have successfully developed an innovative, open-source molecular detection method that is able to detect and quantify the B.1.1.7 (Alpha) […]

Continue Reading

US scientists design novel “trap” for COVID-19

May 24, 2021

Researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have come up with a novel way to trap SARS-CoV-2 viruses, the virus that causes COVID-19, within the body and then use the body’s own immune system to destroy it – using specially-designed “Nanotraps.” In theory, these Nanotraps attract the virus […]

Continue Reading